Topics

The Chronic Obstructive Pulmonary Disease Frequent Exacerbator Phenotype Is Associated with Decreased Upper Airway Microbiota α Diversity.

07:00 EST 1st December 2018 | BioPortfolio

Summary of "The Chronic Obstructive Pulmonary Disease Frequent Exacerbator Phenotype Is Associated with Decreased Upper Airway Microbiota α Diversity."

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease. COPD frequent exacerbators (FEs) suffer increased morbidity and mortality compared with infrequent exacerbators (IEs). Exacerbations are associated with bacterial infection and lung inflammation. Our overall objective was to determine features that differentiate the oral and sputum microbiota of FEs versus IEs. A total of 11 FEs and 11 IEs provided oral wash and sputum samples. Each sample and control underwent DNA extraction, 16S V4 rRNA amplification, 16S V4 sequencing, and quantitative PCR of 16S rRNA. Data were analyzed using QIIME and R. FEs and IEs demonstrated no significant differences in mean age, FEV % predicted, pack-years of tobacco exposure, or St. George's Respiratory Questionnaire score. No differences in oral wash or sputum 16S copy numbers were observed based on phenotype. Shannon diversity was significantly greater in oral samples compared with sputum (P = 0.002), and IE samples were more diverse than FE samples (P = 0.02). No differences in oral wash taxa related to COPD phenotype were observed. The four most common genera in sputum differed by exacerbation phenotype: FE sputum contained Haemophilus, Streptococcus, Veillonella, and Moraxella; IE sputum contained Streptococcus, Veillonella, Prevotella, and Haemophilus. One operational taxonomic unit (Actinomyces) was significantly more abundant in IE versus FE sputum (P = 0.048, Wilcoxon rank-sum test). Principal coordinate analysis using Bray-Curtis distance with permutational multivariate analysis of variance analyses demonstrated clustering by anatomic site (P = 0.016), phenotype (P = 0.025), inhaled corticosteroid use (P = 0.045), current tobacco use (P = 0.024), COPD severity (P = 0.003), and recent dental cleaning (P = 0.006). In conclusion, FEs have less diverse oral and sputum microbiota than IEs. FE sputum contained more Haemophilus and Moraxella compared with IE sputum, but this difference was not statistically significant. The oral and sputum microbiota of subjects with COPD demonstrated clustering based on exacerbation phenotype, inhaled corticosteroid use, tobacco use, severity of obstruction, and dental care habits.

Affiliation

Journal Details

This article was published in the following journal.

Name: Annals of the American Thoracic Society
ISSN: 2325-6621
Pages: S286

Links

DeepDyve research library

PubMed Articles [25019 Associated PubMed Articles listed on BioPortfolio]

COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.

Frequent chronic obstructive pulmonary disease (COPD) exacerbators are at a higher risk of adverse health outcomes when compared to infrequent exacerbators. A COPD frequent exacerbator phenotype and i...

Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.

At present, there is little information in Bulgaria regarding the rate and stability of frequent-exacerbation phenotype in COPD patients.

Acute exacerbations of chronic obstructive pulmonary disease experiences among chronic obstructive pulmonary disease patients with comorbid gastroesophageal reflux disease.

To explore perceptions of experience exacerbations of chronic obstructive pulmonary disease among chronic obstructive pulmonary disease patients with comorbid gastroesophageal reflux disease by focusi...

Nitrosative stress in asthma-chronic obstructive pulmonary disease overlap.

Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) has frequent exacerbations, and a poor quality of life and prognosis compared to COPD alone. However, the pathogenesis of ACO has not ...

Effectiveness of tele-monitoring by patient severity and intervention type in chronic obstructive pulmonary disease patients: A systematic review and meta-analysis.

Chronic obstructive pulmonary disease is a major burden on healthcare systems worldwide. Tele-monitoring has recently been used for management of chronic obstructive pulmonary disease patients.

Clinical Trials [16419 Associated Clinical Trials listed on BioPortfolio]

Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease is a serious disease . Exacerbations of Chronic obstructive pulmonary disease is an acute worsening condition of Chronic obstructive pulmonary disease...

Relationship Between Metabolic Profile and Clinical Phenotype in Chronic Obstructive Pulmonary Disease

Despite the high prevalence of chronic obstructive pulmonary disease (COPD), there continues to be a large gap in our understanding of disease pathogenesis and mechanisms accounting for la...

Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease

In addition to chronic airflow obstruction, patients with Chronic Obstructive Pulmonary Disease (COPD) suffer from skeletal muscle dysfunction which is a prominent and disabling feature an...

Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients

Chronic obstructive pulmonary disease (COPD) is a chronic condition involving an impairment in functionality and in the execution of activities of daily life. The hypothesis of this study ...

Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of Whey

Chronic obstructive pulmonary disease is characterized by obstruction to pulmonary airflow and dyspnea. These characteristics are a consequence of exposure to harmful gases and particles t...

Medical and Biotech [MESH] Definitions

A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.

A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.

A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

Quick Search


DeepDyve research library

Relevant Topics

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Searches Linking to this Article